BIOMOTIV, LLC

Profile

Company Names

BIOMOTIV, LLC

Addresses

20600 CHAGRIN BLVD., SUITE 210, CLEVELAND, OH 44122

3605 WARRENSVILLE CENTER ROAD, MSC 2394, SHAKER HEIGHTS, OH 44122

Phone Numbers

216 455 3216

 

Entity Type:

LIMITED LIABILITY COMPANY

Industry:

BIOTECHNOLOGY

Year Incorporated:

2010

State Incorporated:

DELAWARE

Total Amount Raised:

$145,726,790.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2012-08-22 
$145,726,790.00 
$200,000,000.00 
$54,273,210.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
CARMEN 
 
BOZIC, M.D. 
DIRECTOR
BIOMOTIV, LLC
CARMEN 
 
BOZIC, MD 
DIRECTOR
BIOMOTIV, LLC
ACHILLES 
A. 
DEMETRIOU, M.D., PH.D. FACS 
DIRECTOR
BIOMOTIV, LLC
JEFFREY 
 
EDELSON, MD 
EXECUTIVE OFFICER
BIOMOTIV, LLC
RONALD 
G. 
HARRINGTON 
DIRECTOR
BIOMOTIV, LLC
GRAEME 
 
MARTIN 
DIRECTOR
BIOMOTIV, LLC
GRAEME 
 
MARTIN, PH.D. 
DIRECTOR
BIOMOTIV, LLC
MICHAEL 
 
MARTIN, PH.D. 
DIRECTOR
BIOMOTIV, LLC
CHARLES 
 
MCOSKER, PH.D. 
EXECUTIVE OFFICER
BIOMOTIV, LLC
ROBERT 
S. 
REITMAN 
DIRECTOR
BIOMOTIV, LLC
BAIJU 
 
SHAH 
EXECUTIVE OFFICER, DIRECTOR
ORCA PHARMACEUTICALS, LLC   |  DUAL THERAPEUTICS, LLC   |  BIOMOTIV, LLC   |  OPTIKIRA, LLC   |  SUJANA BIOTECH, LLC   |  Z53 THERAPEUTICS, LLC   |  ALLINAIRE THERAPEUTICS, LLC   |  SAPVAX, LLC
BAIJU 
R. 
SHAH 
EXECUTIVE OFFICER, DIRECTOR
BIOMOTIV, LLC
JONATHAN 
S. 
STAMLER, M.D. 
DIRECTOR
BIOMOTIV, LLC
STACIE 
 
SWITZER 
EXECUTIVE OFFICER
NEOS THERAPEUTICS, INC.   |  BLUECAVA, INC.   |  BIOMOTIV, LLC
MARK 
 
TEAGUE 
EXECUTIVE OFFICER
BIOMOTIV, LLC
TED 
 
TORPHY, PH.D. 
EXECUTIVE OFFICER
BIOMOTIV, LLC
THEODORE 
 
TORPHY, PH.D. 
EXECUTIVE OFFICER
BIOMOTIV, LLC
DAVID 
C. 
U-PRICHARD, PH.D. 
EXECUTIVE OFFICER, DIRECTOR
BIOMOTIV, LLC
TERRY 
 
VANCE 
EXECUTIVE OFFICER
EKOS CORP   |  BIOMOTIV, LLC   |  SAPVAX, LLC   |  AMPLO BIOTECHNOLOGY, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2018-08-01
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-08-22 
2017-08-04
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-08-22 
2016-08-05
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-08-22 
2015-08-06
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-08-22 
2014-08-07
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2012-08-22 
2013-08-06
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2012-08-22 
2012-09-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2012-08-22 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#